QT
SLDB icon

Quantbot Technologies’s Solid Biosciences SLDB Stock Holding History

Quantbot Technologies’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.3K Buy
9,635
+8,635
+864% +$65.5K ﹤0.01% 1481
2026
Q1 		$7.2K Buy
+1,000
New +$6.42K ﹤0.01% 1557
2018
Q3 		– Sell
-163
Closed -$87K – 1522
2018
Q2 		$87K Buy
+163
New +$50.2K 0.01% 901

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quantbot Technologies's SLDB Position: Q2 2026 in Review

Quantbot Technologies increased its Solid Biosciences (SLDB) stake by 864% in Q2 2026, buying an estimated $65.5K and bringing the position to 9,635 shares worth $96.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1481.

Quantbot Technologies first reported a position in SLDB in Q2 2018 and has held it in 3 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Quantbot Technologies held 9,635 shares of Solid Biosciences worth $96.3K as of Q2 2026.
  • Quantbot Technologies bought 8,635 Solid Biosciences shares in Q2 2026, an estimated $65.5K.
  • Solid Biosciences made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1481 holding.
  • Quantbot Technologies first reported a position in Solid Biosciences in Q2 2018 and has held it in 3 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.